Predictive factors of catch-up growth in term, small for gestational age infants: a two-year prospective

Fadila Bouferoua1, Mohamed El Mokhtar Khiari1, Nafissa Benhalla1

  • 1Pediatric Department "A", Beni Messous Hospital, Algiers, Algeria.

Insights

Most small for gestational age (SGA) infants achieve catch-up growth. However, 12.1% of term SGA infants in Algeria did not achieve catch-up growth by 2 years, indicating a need for continued monitoring and potential growth-promoting treatment.

Area of Science:

  • Pediatrics
  • Neonatology
  • Endocrinology

Background:

  • Most infants born small for gestational age (SGA) experience catch-up growth.
  • A minority of SGA infants fail to achieve adequate growth, potentially benefiting from interventions.
  • Identifying risk factors for failed catch-up growth is crucial for targeted management.

Purpose of the Study:

  • To determine the prevalence of failure to achieve catch-up growth in term SGA infants.
  • To identify risk factors associated with the lack of catch-up growth in this population.
  • To inform potential growth-promoting treatment strategies and national follow-up programs.

Main Methods:

  • Prospective observational study of term infants (37-42 weeks gestation) with birth weight below the 10th percentile.
  • Measurements of length, weight, and head circumference from birth to 2 years of age.
  • Multivariate analysis to identify independent predictors of failure to show catch-up growth.

Main Results:

  • Out of 457 term SGA infants, 12.1% exhibited persistent short stature at 24 months.
  • Independent predictors of failed catch-up growth included maternal height <150 cm, significant difference between mid-parental height and birth length, and SGA history.
  • Other factors identified were low ponderal index and shorter duration of breastfeeding.

Conclusions:

  • This study provides epidemiological data on SGA in Algeria and factors influencing post-natal growth.
  • Identifying children with persistent short stature at 2 years allows for targeted follow-up and consideration of growth hormone therapy.
  • Results support establishing a national program for SGA infant registration and re-evaluation at 2 years.
Abstract